TVTX
Travere Therapeutics Inc
Biopharmaceutical company focused on rare kidney and metabolic diseases
CUSIP: 89422G107HealthcareUS1 holder
Total Value
$50.55M
Total Shares
2.90M
Net Share Change
+2.90M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$50.55M2.90M sharesNEW